Vascular Endothelial Growth Factor -460 C/T BstUI Gene Polymorphism is associated with Primary Open Angle Glaucoma
Tóm tắt
Hypoxia and nitric oxide (NO) play important roles in the onset and progression of glaucoma. Vascular endothelial growth factor (VEGF) is one of the main factors responsive to hypoxia and NO. In this study, we investigated the association between the BstUI C/T VEGF gene polymorphism and primary open angle glaucoma (POAG). 60 POAG patients and 78 healthy volunteers were enrolled in this study. The most frequently observed polymorphism in the VEGF gene is BstUI C/T, which was located 460 nucleotides upstream of the gene. The polymorphism was observed using polymerase chain reaction-based restriction analysis. Significant differences were observed in the distribution of the polymorphism between control subjects and POAG patients (p = 0.003). C/C homozygotes are absent in the control group; therefore, this genotype represents a suitable genetic maker for POAG. Hypoxia and NO may be involved in the pathway whereby the VEGF-460 polymorphism regulates POAG. Furthermore, homozygous C/C VEGF genotype is a useful maker for Chinese POAG. Hypoxia and nitric oxide (NO) play important roles in the onset and progression of glaucoma. Vascular endothelial growth factor (VEGF) is one of the main factors responsive to hypoxia and NO. In this study, we investigated the association between the BstUI C/T VEGF gene polymorphism and primary open angle glaucoma (POAG). 60 POAG patients and 78 healthy volunteers were enrolled in this study. The most frequently observed polymorphism in the VEGF gene is BstUI C/T, which was located 460 nucleotides upstream of the gene. The polymorphism was observed using polymerase chain reaction-based restriction analysis. Significant differences were observed in the distribution of the polymorphism between control subjects and POAG patients (p = 0.003). C/C homozygotes are absent in the control group; therefore, this genotype represents a suitable genetic maker for POAG Hypoxia and NO may be involved in the pathway whereby the VEGF-460 polymorphism regulates POAG. Furthermore, homozygous C/C VEGF genotype is a useful maker for Chinese POAG.
Tài liệu tham khảo
Galassi F, Sodi A, Ucci F, Renieri G, Pieri B, Masini E. Ocular haemodynamics and nitric oxide in normal pressure glaucoma. Acta ophthalmol Scand 2000; 78: 37–38.
Chung HS, Harris A, Evans DW, Kagemann L, Garzozi HJ, Martin B. Vascular aspects in the pathophisology of glaucomatous optic neuropathy. Surv Ophthalmol 43(suppl.1): S43–50
Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J of Biol Chem 1995;270:13333–40.
Neufeld AH, Sawada A, Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chnonic glaucoma. Proc. Natl. Acad. Sci 1999; 96: 9944–48.
Lin Y, Cox SR, Morita T, Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5’ dnhancer Circ Res 1995;77: 638–43.
Chung HS, Harris A, Evans DW, Kagemann L, Garzozi HJ, Martin B. Vascular aspects in the pathophisology of glaucomatous optic neuropathy. Surv Ophthalmol 43 (suppl. 1)1999:S43–50.
Nathanson JA. Mckee M. Alternations of ocular nitric oxide synthase in human glaucoma. Invest Ophthalmol Vis Sci. 1995; 36: 1774–84.
Armaly MF, Krueger DE, Maunder L, Becker B, Hetherington J, Jr Kolker AE, Levene RZ, Maumenee AE, Pollack IP, Shaffer RN. Biostatistical analysis of the collaborative glaucoma study. Summary report of the risk factors. Arch Ophthalmol 1980; 98: 2163–71
Kimura H, Weisz A, Kurashima Y, Hashimoto K, Tsutomu Ogura, Fulvio D’Acquisto, Raffaelo Addeo, Masatoshi Makundri, Esumi H. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 2000; 95: 189–97.
Guang L., Wang GL, Semenza GL. Characterization of hypoxia-inducible factor. 1 and regulation of DNA binding activity by hypoxia. J of Biol Chem 1993; 29: 21513–18.
Steinbrech DS, Mehrara BJ, Saadeh PB, Greenwald JA, Spector JA, Gittes GK, MT. VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism. Am J Physical Cell Physiol. 2000; 278: C853–60.
Kimura H, Weisz A, Ogura T, Hitomi Y, Kurashima Y, Hashinoto K, D’Acquists F, Makunchi M, Esumi H. Identification of hypoxia-inducible factor-1 Ancillary sequence and its function in Vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J Biol Chem 2001; 276: 2292–98.
Akeno N, Czyzyk-Krzeska MF, Gross TS, Clemens TL. Hypoxia induces vascular endothelial growth factor gene transcription in human osteoblast like cells through the hypoxia inducible factor 2α. Endocrinology 1991; 142: 959–62.
Hideo Kimura H, Weisz A. Kurashima, Hashimoto K, Ogura T, D’Acquisto F, Addeo R, Makuuchi M, Esumi H. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nictric oxide. Blood 2000; 95: 189–97.
Klagsbrun M, D’Amore PA. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev 1996; 7: 259–70
Jackson MW, Bentel JM, Tilley WD. Vascular endothelial growth factor (VEGF) expression in prostate cancer and begin prostatic hyperplasia. J Urol 1997; 157: 2323–8
Lin HJ, Tsai FJ, Chen WC, Hsu CD, Tsai SW. Association of Interleukin - I Beta and Receptor Antagonist Gene Polymorphisms with Primary Open Angle Glaucoma. Ophthalomiga 2003; 217: 358–64.
Lin HJ, Tsai FJ, Chen WC, Shi YR, Hsu Y, Tsai SW. Association of Tumor Necrosis Factor Alpha-308 Gene Polymorphism with Primary Open Angle Glaucoma in Chinese. Eye 2003; 17: 31–34.
Stone EM, Fingert JH, Alward WLM, et al. Identification of a gene that causes primary open angle glaucoma. Science 1997; 275: 668–70.
Nickells RW. Apoptosis of retinal ganglion cells in glaucoma: an update of the molecular pathways involved in cell death. Surv ophthalmol 1999; 43: S151–61.
Lin HJ, Chen WC, Tsai FJ, Tsai SW. Distributions of p53 codon 72 polymorphism in primary open angle glaucoma. Br J Ophthalmol 2002; 86: 767–70